[Translation] A multicenter, open-label, dose-escalation phase Ia clinical trial to evaluate the safety, tolerability and preliminary efficacy of STSG-0002 injection in patients with asymptomatic chronic HBV infection
评价STSG-0002注射液对无症状慢性HBV感染者的安全性、耐受性、药代动力学(PK)、药效动力学(PD)及免疫原性。
[Translation] To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of STSG-0002 injection in patients with asymptomatic chronic HBV infection.